Analysis of Mortality Factors in COVID-19 Patients; Systematic Review
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The increase in the number of COVID-19 cases is progressing quickly and has been spread between countries. As of October 14, 2020, there are 213 countries/regions around the world that have reported Covid-19 with a total of 38,002,699 confirmed cases of which 1,083,234 died. The purpose of this study was to determine the relationship between mortality factors and mortality in COVID-19 patients to predict the patient's prognosis. This research method is a systematic review through a literature review on mortality factors in COVID-19 patients Literature searches were accessed through internet searches using the Pubmed database based on the preferred reporting items for systemic review and meta-analysis (PRISMA). A systematic search was carried out on 18 October - 20 October 2020 with the keywords “COVID-19” AND “Death” OR “Decease” AND “Factor Associated”. There were 8 literature selected that met the inclusion and exclusion criteria. Based on the findings of the eight journals, mortality is old age, male, has a clinical condition of hypertension, obesity, diabetes, cardiovascular disease, lung disease, neurological disease, lymphophenia laboratory test results, hyperlactate dehydrogenase, increased procalcitonin, increased neutrophils, increased C-reactive protein, and increased D-dimer. All literature reported that a p value <0.05 was obtained from the analysis of the relationship between mortality factors and cases of death in COVID-19 patients. There is a significant relationship between mortality factors and the death of COVID-19 patients, where the mortality factors are elderly, male, have a clinical condition of hypertension, obesity, diabetes, cardiovascular disease, lung disease, neurological disease, lymphophenia laboratory test results, hyperlactate dehydrogenase, increase in procalcitonin, increase in neutrophils, increase in C-reactive protein, and increase in D-dimers in which the prognosis of patients who have mortality factors tends to be worse.
Keywords: Mortality, Coronavirus, COVID-19
[2 Wang L, Wang Y, Ye D, & Liu Q. Review of the 2019 Novel Coronavirus (SARS-CoV-2) Based on Current Evidence. Int J Antimicrob Agents. 2020;105948.
[3 World Health Organization. WHO Indonesia. 2020. [Disitasi 14 Oktober 2020]. Tersedia di: https://covid19.who.int/region/searo/country/id
[4 Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Jakarta: Kementerian Kesehatan Republik Indonesia. 2020.
[5 Burke RM, Killerby ME, Newton S, et al. Symptom Profiles of a Convenience Sample of Patients With Covid-19—United States, January–April 2020. Morbidity and Mortality Weekly Report. 2020: 69(28), 904.
[6 Huang C, Wang Y, et al. Clinical Features Of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506.
[7 Guan Wei-jie, Yi Zheng, et al. Clinical Characteristics of 2019 Novel Coronavirus Infection in China. MedRxiv. 2020.
[8 Huang Chaolin, Wang Y, et al. Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. The lancet. 2020, 395.10223: 497-506.
[9 Hu Zhiliang, Song Ci, et al. Clinical Characteristics of 24 Asymptomatic Infections With COVID-19 Screened Among Close Contacts in Nanjing, China. Science China Life Sciences. 2020: 63.5: 706-711.
[10 Gandhi RT, Lynch JB & del Rio C. Mild or Moderate COVID-19. New England Journal of Medicine. 2020.
[11 Berlin DA, Gulick RM & Martinez FJ. Severe Covid-19. New England Journal of Medicine. 2020.
[12 Razzaghi H, Wang Y Lu, et al. Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated With Increased Risk for Severe Covid-19 Illness- United States. Morbidity and Mortality Weekly Report. 2020: 69(29), 945.
[13 Banerjee Indrajit, Mohabeer P, et al. COVID-19: Recent Advances In Epidemiology, Virology, Etiopathogenesis, Clinical Trials And Vaccine Development. Journal of Biomedical Sciences. 2020: 7.1: 18-27.
[14. Li Xiaochen, Xu Shuyun, et al. Risk factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 2020.
[15 Gold Jeremy AW. Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19- United States, May- August 2020. Morbidity and Mortality Weekly Report. 2020: 69.
[16 Lee Lennard YW, Cazier JB, et al. COVID-19 Mortality in Patients with Cancer on Chemotherapy or Other Anticancer Treatments: A Prospective Cohort Study. The Lancet. 2020.
[17 Xie J, Covassin N, et al. Association Between Hypoxemia and Mortality in Patients with COVID-19. In Mayo Clinic Proceedings. Elsevier. 2020.
[18 Turcotte Justin J, Meisenberg BR, et al. Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital. PloS one. 2020;15(8), e0237558.
[19 Yu Caizheng, Lei Qing, et al. Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China. American Journal of Preventive Medicine. 2020.
[20 Sousa GJB, Garces TS, et al. Mortality and survival of COVID-19. Epidemiology & Infection. 2020.
[21 Pan Feng, Yang L, et al. Factors Associated with Death Outcome in Patients with Severe Coronavirus Disease-19 (COVID-19): A Case-Control Study. International Journal of Medical Sciences. 2020: 17.9: 1281-1292.
[22 Shi Qiao, Zhang Xiaoyi, et al. Clinical Characteristics and Risk Factors For Mortality of COVID-19 Patients with Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020.
[23 Sun Haiying, Ning Ruoqi, et al. Risk factors for mortality in 244 older adults with COVID‐19 in Wuhan, China: A Retrospective Study. Journal of the American Geriatrics Society. 2020.
[24 Zhang J, Wang X, et al. Risk Factors for Disease Severity, Unimprovement, and Mortality of COVID-19 Patients in Wuhan, China. Clinical Microbiology and Infection. 2020.
[25 Palaiodimos L, Kokkinidis DG, et al. Severe obesity, Increasing Age and Male Sex Are Independently Associated Wwth Worse in-Hospital Outcomes, and Higher in-Hospital Mortality, in a Cohort of Patients with COVID-19 in the Bronx, New York. Metabolism. 2020: 108, 154262.
[26 The Joanna Briggs Institute. Checkclist for Cohort Studies. Joanna Briggs Institute. 2017. https://joannabriggs.org/critical-appraisal-tools
[27 The Joanna Briggs Institute. Checkclist for Case Control Studies. Joanna Briggs Institute. 2017. https://joannabriggs.org/critical-appraisal-tools
[28. The Joanna Briggs Institute. Checkclist for Analytic Cross Sectional Studies. Joanna Briggs Institute. 2017. https://joannabriggs.org/critical-appraisal-tools
[29 Zheng Z, Peng F, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection. 2020.
[30 Noor F. M. & Islam M. M. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. Journal of Community Health. 2020: 1-13.
[31 Felsenstein S, Herbert JA, et al. COVID-19: Immunology and treatment options. Clin Immunol. 2020: 108448.
[32 Prompetchara E, Ketloy C, et al. Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned form SARS and MERS Epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1-9.
Copyright (c) 2021 International Journal of Science, Technology & Management
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.